22
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
6.523
Exchange
XHKG - Hong Kong Exchange
40.3 B
Last period Equity ,CNY
405%
Equity has increased in 5 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also WuXi Biologics
Company Analysis
2269.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2269.HK financial analysis by Eyestock methodology
Valuation
2269.HK valuation using historical relative method
Statements
2269.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2269.HK dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
WuXi Biologics`s Equity for the period ended 2023-12-31 is 40.3 B CNY
